These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15243861)
1. BIO 2004 Annual International Convention. Part I. 6-9 June 2004, San Francisco, CA, USA. Williams L IDrugs; 2004 Jul; 7(7):633-5. PubMed ID: 15243861 [No Abstract] [Full Text] [Related]
2. BIO 2004 Annual International Convention. Part II. 6-9 June 2004, San Francisco, CA, USA. Williams L IDrugs; 2004 Jul; 7(7):636-8. PubMed ID: 15243862 [No Abstract] [Full Text] [Related]
3. BIO 2008 Annual International Convention - Part 1. Shumoogam J IDrugs; 2008 Sep; 11(9):621-4. PubMed ID: 18763206 [No Abstract] [Full Text] [Related]
4. BIO 2008 Annual International Convention - Part 2. Shumoogam J IDrugs; 2008 Sep; 11(9):624-6. PubMed ID: 18763207 [No Abstract] [Full Text] [Related]
5. Drug companies decline to cooperate. Williams N Science; 1997 Dec; 278(5344):1704. PubMed ID: 9411786 [No Abstract] [Full Text] [Related]
6. BIO 2006 Annual International Convention. The current state of the global biotechnology industry. Zarkowska T IDrugs; 2006 Jun; 9(6):381-2. PubMed ID: 16752301 [No Abstract] [Full Text] [Related]
7. BIO 2006 Annual International Convention. The expanding biotech industry of France. Zarkowska T IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302 [No Abstract] [Full Text] [Related]
8. An audience with...Marc Cluzel. Cluzel M Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024 [TBL] [Abstract][Full Text] [Related]
9. Daniel Vasella. Hughes B Nat Rev Drug Discov; 2010 Feb; 9(2):98. PubMed ID: 20118958 [No Abstract] [Full Text] [Related]
11. Private sector contributions to pharmaceutical science: thirty-five summary case histories. Zycher B; DiMasi JA; Milne CP Am J Ther; 2010; 17(1):101-20. PubMed ID: 20027102 [TBL] [Abstract][Full Text] [Related]
12. Pierre Meulien. Meulien P; Mullard A Nat Rev Drug Discov; 2015 Aug; 14(8):521. PubMed ID: 26228752 [No Abstract] [Full Text] [Related]
13. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy. Tear S; Zarkowska T IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303 [No Abstract] [Full Text] [Related]
15. Biotech R&D still reeling. Lawrence S Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460 [No Abstract] [Full Text] [Related]
16. Genentech grapples with direct offer. Huggett B Nat Biotechnol; 2009 Mar; 27(3):212. PubMed ID: 19270652 [No Abstract] [Full Text] [Related]
17. Row over industry link-up splits staff of Spanish lab. Fernandez Hermana LA Nature; 1994 Dec; 372(6507):586. PubMed ID: 7990935 [No Abstract] [Full Text] [Related]
18. Eurofile. Private-public drive to cut delays in drug development. Mundell I Eur J Cancer; 2008 Jan; 44(2):169. PubMed ID: 18335586 [No Abstract] [Full Text] [Related]
19. [Does the public sector have an independent research role in the development of drugs?]. Poulsen HE; Grønlykke TB Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828 [TBL] [Abstract][Full Text] [Related]
20. A new era of hope for the world's most neglected diseases. The PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]